open access

Vol 5, No 1 (2004): Practical Diabetology
Original articles (submitted)
Published online: 2004-02-02
Get Citation

Cost of Diabetes Type 2 in Poland (CODIP)

Ida Kinalska, Maciej Niewada, Cezary Głogowski, Anna Krzyżanowska, Jakub Gierczyński, Maciej Łatek, Bogumił Kamiński
Diabetologia Praktyczna 2004;5(1):1-8.

open access

Vol 5, No 1 (2004): Practical Diabetology
Original articles (submitted)
Published online: 2004-02-02

Abstract

INTRODUCTION. The Cost of Diabetes Type 2 in Poland (CODIP) is multicenter, bottom-up designed, retrospective study aimed at evaluation of total cost of diabetes type 2 in Poland. Study design reflects that of CODE-2 (Cost of Diabetes Type 2 in Europe) and allows for international comparison.
MATERIAL AND METHODS.
Patients diagnosed with type 2 diabetes mellitus were randomly selected from outpatients charts databases and surveyed. Both patient and practitioner questionnaires collected data from each patient on: clinical characteristic, medical and other resources used, quality of life. Total treatment costs were calculated using drug retail and medical procedures prices. Indirect costs were estimated by human capital approach. The impact of complications on total costs was evaluated. Values are expressed in PLN and also presented in Euro value (PPP ‘2002 value: 1 EUR = 2.05 PLN).
RESULTS. 303 patients were enrolled (mean age: 61, mean time from diagnosis: 10.86 year, males: 49%). The total annual treatment costs amounted to 9227.20 PLN (4501.08 EUR), including 2429.95 PLN (1185.35 EUR) of direct costs. The direct cost structure: 11.1% physicians consultations, 2.9% paramedics, 17.3% oral antidiabetic drug, 29.1% insulins, 29.6% hospital costs, 0.8% emergency services, 9.2% laboratory tests. The indirect costs are mainly determined by early retirements or pension and relatives care costs.
CONCLUSIONS. Economic impact of diabetes type 2 in Poland is considerable. Drug prescription patterns, especially for insulin, are responsible for large part of direct costs.

Abstract

INTRODUCTION. The Cost of Diabetes Type 2 in Poland (CODIP) is multicenter, bottom-up designed, retrospective study aimed at evaluation of total cost of diabetes type 2 in Poland. Study design reflects that of CODE-2 (Cost of Diabetes Type 2 in Europe) and allows for international comparison.
MATERIAL AND METHODS.
Patients diagnosed with type 2 diabetes mellitus were randomly selected from outpatients charts databases and surveyed. Both patient and practitioner questionnaires collected data from each patient on: clinical characteristic, medical and other resources used, quality of life. Total treatment costs were calculated using drug retail and medical procedures prices. Indirect costs were estimated by human capital approach. The impact of complications on total costs was evaluated. Values are expressed in PLN and also presented in Euro value (PPP ‘2002 value: 1 EUR = 2.05 PLN).
RESULTS. 303 patients were enrolled (mean age: 61, mean time from diagnosis: 10.86 year, males: 49%). The total annual treatment costs amounted to 9227.20 PLN (4501.08 EUR), including 2429.95 PLN (1185.35 EUR) of direct costs. The direct cost structure: 11.1% physicians consultations, 2.9% paramedics, 17.3% oral antidiabetic drug, 29.1% insulins, 29.6% hospital costs, 0.8% emergency services, 9.2% laboratory tests. The indirect costs are mainly determined by early retirements or pension and relatives care costs.
CONCLUSIONS. Economic impact of diabetes type 2 in Poland is considerable. Drug prescription patterns, especially for insulin, are responsible for large part of direct costs.
Get Citation

Keywords

Diabetes Mellitus Type 2; cost; cost analysis; pharmacoeconomics; CODIP; CODE-2

About this article
Title

Cost of Diabetes Type 2 in Poland (CODIP)

Journal

Clinical Diabetology

Issue

Vol 5, No 1 (2004): Practical Diabetology

Pages

1-8

Published online

2004-02-02

Bibliographic record

Diabetologia Praktyczna 2004;5(1):1-8.

Keywords

Diabetes Mellitus Type 2
cost
cost analysis
pharmacoeconomics
CODIP
CODE-2

Authors

Ida Kinalska
Maciej Niewada
Cezary Głogowski
Anna Krzyżanowska
Jakub Gierczyński
Maciej Łatek
Bogumił Kamiński

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl